Nervous System Origin of Renal Galactosylceramide in the Twitcher Mouse Mutant
Globoid cell leukodystrophy (GLD, Krabbe disease) is a rare genetic disorder caused by a catalyc deficiency of galactosylceramide (EC 22.214.171.124) (Suzuki and Suzuki, 1970). One of the unusual features of the disease is the absence of abnormal accumulation of galactosylceramide in the nervous system or in the kidney despite the genetic block in its degradative pathway (Suzuki, 1971; Vanier and Svennerholm, 1974). Genetically equivalent diseases with similar clinical and pathological manifestations occur in the dog, mouse, sheep, and probably also in the cat (Suzuki and Suzuki, 1985). In the central nervous system of affected dogs and mice, abnormal accumulation of galactosylceramide also does not occur. In contrast, an enormous accumulation of galactosylceramide is observed in the kidney of affected mice (the twitcher mutant) (Ida et al., 1982; Igisu et al., 1983) and to a lesser extent in the kidney of affected dogs (Igisu, Katayama and Suzuki, unpublished observations).
KeywordsGenetic Status Abnormal Accumulation Radioactivity Incorporation Twitcher Mouse Affected Mouse
Unable to display preview. Download preview PDF.
- Abramson, M. B., Norton, W. T., and Katzman, R., 1965, Study of ionic structures in phospholipids by infrared spectra, J.Biol.Chem., 240: 2389–2395.Google Scholar
- Folch-Pi, J., Lees, M. B., and Sloane-Stanley, G. H., 1957, A simple method for the isolation and purification of total lipids from animal tissue, J.Biol.Chem., 226: 497–509.Google Scholar
- Kobayashi, T., Shinnon, N., Goto, I., Kuroiwa, Y., Okawauchi, M., Sugihara, T., and Tanaka, M., 1985a, Galactosylceramide and lactosylceramide-loading studies in cultured fibroblasts from normal individuals and patients with globoid cell leukodystrophy (Krabbe’s disease), Biochim.Biophys.Acta, 835: 456–464.CrossRefGoogle Scholar
- Kobayashi, T., Shinnon, N., Goto, I., Kuroiwa, Y., 1985b, Hydrolysis of galactosylceramide is catalyzed by two genetically distinct acid β-galactosidases, J.Biol.Chem., 260: 14982–14987.Google Scholar
- Suzuki, K. and Suzuki, Y., 1983, Galactosylceramide lipidosis: Globoid cell leukodystrophy (Krabbe’s disease), in: “The metabolic Basis of Inherited Disease”, 5th edition, J. B. Stanbury, J. B. Wyngaarden, D. S. Fredrickson, J. L. Goldstein and M. S. Brown, eds., McGraw-Hill, New York.Google Scholar
- Svennerholm, L., Vanier, M. T., and Mansson, J.-E., 1980, Krabbe disease: A galactosylsphingosine (psychosine) lipidosis, J.Lipid Res., 21: 53–64.Google Scholar
- Takahashi, H., Igisu, H., Suzuki, K., and Suzuki, K., 1983, Murine globoid cell leukodystrophy (the twitcher mouse): Presence of characteristic inclusions in kidney and lymph nodes, Am.J.Path., 112: 147–154.Google Scholar
- Takanashi, H., Igisu, H., Suzuki, K., and Suzuki, K., 1984, Murine globoid cell leukodystrophy: The twitcher mouse. An ultrastructu-ral study of the kidney, Lab.Invest., 50: 42–50.Google Scholar
- Vanier, M. T., and Svennerholm, 1974, Chemical pathology of Krabbe’s disease. I. Lipid composition and fatty acid patterns of phosphoglycerides in brain, Acta Paediat.Scand., 63: 469–500.Google Scholar